We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

253 hedge funds and large institutions have $3.16B invested in IDEAYA Biosciences in 2026 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 87 increasing their positions, 75 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 32

20% more call options, than puts

Call options by funds: $46.7M | Put options by funds: $39M

16% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 75

3% more funds holding

Funds holding: 246 → 253 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

5% less capital invested

Capital invested by funds: $3.32B → $3.16B (-$159M)

1.58% less ownership

Funds ownership: 109.41% → 107.83% (-1.6%)

Holders
253
Holders Change
+7
Holders Change %
+2.85%
% of All Funds
3.11%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
45
Increased
87
Reduced
75
Closed
32
Calls
$46.7M
Puts
$39M
Net Calls
+$7.65M
Net Calls Change
-$22.8M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$20.4M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$14.3M
3
BNP Paribas Asset Management
BNP Paribas Asset Management
France
+$13.5M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$13.2M
5
BBA
Baker Bros. Advisors
New York
+$11M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$50.9M
2
DM
Deerfield Management
New York
-$20.9M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$13.7M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$13M
5
State Street
State Street
Massachusetts
-$11.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
TFA
226
Transamerica Financial Advisors
Florida
$3.37K +$1.34K +40 +66%
RF
227
Rossby Financial
Florida
$2.89K +$2.99K +89 New
WB
228
Webster Bank
Connecticut
$2.63K – – –
WA
229
WPG Advisers
Maryland
$2.47K – – –
AW
230
Avion Wealth
Texas
$2K – – –
CA
231
CoreCap Advisors
Michigan
$2K – – –
GCM
232
Gables Capital Management
Florida
$1.67K – – –
PFBT
233
Parkside Financial Bank & Trust
Missouri
$1.67K – – –
PPC
234
Park Place Capital
Alabama
$1.33K – – –
RFP
235
Root Financial Partners
California
$1.17K +$1.17K +35 New
BTI
236
Blue Trust Inc
Georgia
$1.07K – – –
HFS
237
Hantz Financial Services
Michigan
$1K – – –
PWMG
238
Private Wealth Management Group
New Jersey
$933 – – –
CFM
239
Cornerstone Financial Management
Massachusetts
$900 – – –
FFO
240
Fortitude Family Office
Arizona
$866 – – –
KFAS
241
Keating Financial Advisory Services
Kansas
$833 +$839 +25 New
National Bank of Canada
242
National Bank of Canada
Quebec, Canada
$799 +$805 +24 New
TC
243
Trust Company
Kansas
$666 – – –
BIA
244
Bell Investment Advisors
California
$600 – – –
TWD
245
True Wealth Design
Ohio
$600 – – –
SS
246
SBI Securities
Japan
$400 – – –
JWM
247
JPL Wealth Management
Colorado
$334 +$335 +10 New
CFO
248
CVA Family Office
Colorado
$333 +$335 +10 New
VWM
249
Vermillion Wealth Management
Minnesota
$200 +$201 +6 New
EP
250
Essential Partners
California
$167 – – –
8 9
10
11 12

IDYA Hedge Fund Activity: Q1 2026 in Review

253 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2026, worth a combined $3.16B — down 4.8% from $3.32B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new IDYA positions and 32 closed out — a net gain of 13 holders — while 87 added to existing stakes and 75 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $20.4M. The largest seller was Point72 Asset Management, cutting an estimated $50.9M.

  • 253 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2026, up from 246 in Q4 2025.
  • Funds reported $3.16B of IDEAYA Biosciences stock for Q1 2026, down 4.8% quarter-over-quarter.
  • 45 funds opened new IDEAYA Biosciences positions in Q1 2026 and 32 closed out, a net change of +13 holders.
  • The largest IDEAYA Biosciences buyer in Q1 2026 was Morgan Stanley, an estimated $20.4M added.
  • The largest IDEAYA Biosciences seller in Q1 2026 was Point72 Asset Management, an estimated $50.9M sold.

Based on aggregated 13F filings for Q1 2026.